Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations
Found on: Unsplash

Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations

  Plakous Therapeutics released a press release to announce that Protego-PD™, their therapy for infants with necrotizing enterocolitis (NEC), received both the Orphan Drug and Rare Pediatric Disease designations from the FDA. There are…

Continue Reading Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations

The Future Looks Brighter for Premature Babies Thanks to Stem Cell Research and Tissue Engineered Intestines

514 words 10% vs 1741 words 3% Dr. Tracy Grikscheit is a leading surgeon in the field of tissue engineering. Dr. Grikscheit, together with her colleagues at Children’s Hospital Los…

Continue Reading The Future Looks Brighter for Premature Babies Thanks to Stem Cell Research and Tissue Engineered Intestines